Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,485 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alterations in blood proteins in the prodromal stage of bipolar II disorders.
Lee H, Han D, Rhee SJ, Kim J, Lee Y, Kim EY, Park DY, Roh S, Baik M, Jung HY, Lee J, Lee TY, Kim M, Shin H, Kim H, Kim SH, Kwon JS, Ahn YM, Ha K. Lee H, et al. Among authors: shin h. Sci Rep. 2022 Feb 24;12(1):3174. doi: 10.1038/s41598-022-07160-0. Sci Rep. 2022. PMID: 35210508 Free PMC article.
Plasma proteomic data in bipolar II disorders and major depressive disorders.
Lee H, Rhee SJ, Kim J, Lee Y, Kim H, Lee J, Lee K, Shin H, Kim H, Lee TY, Kim M, Kim EY, Kim SH, Ahn YM, Kwon JS, Han D, Ha K. Lee H, et al. Among authors: shin h. Data Brief. 2021 Oct 17;39:107495. doi: 10.1016/j.dib.2021.107495. eCollection 2021 Dec. Data Brief. 2021. PMID: 34825021 Free PMC article.
Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
Lim KS, Kim JR, Choi YJ, Shin KH, Kim KP, Hong JH, Cho JY, Shin HS, Yu KS, Shin SG, Kwon OH, Hwang DM, Kim JA, Jang IJ. Lim KS, et al. Clin Ther. 2008 Oct;30(10):1817-30. doi: 10.1016/j.clinthera.2008.10.013. Clin Ther. 2008. PMID: 19014837 Clinical Trial.
Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers.
Kim TE, Kim BH, Kim J, Kim KP, Yi S, Shin HS, Lee YO, Lee KH, Shin SG, Jang IJ, Yu KS. Kim TE, et al. Clin Ther. 2009 Oct;31(10):2249-57. doi: 10.1016/j.clinthera.2009.10.011. Clin Ther. 2009. PMID: 19922896 Clinical Trial.
11,485 results
You have reached the last available page of results. Please see the User Guide for more information.